BMC Cancer:肝门部胆管癌巨噬细胞浸润的预后意义

2015-12-30 Seven L 译 MedSci原创

肿瘤相关巨噬细胞(TAMs)对促进肿瘤发展和对癌症存活率具有一定影响。但是TAMs对肝门部胆管癌的肿瘤进展和预后的影响是鲜为人知的。研究者分析了手术切除的肝门部胆管癌肿瘤标本(n = 47)中ATMs的分布和定位,以CD68的表达为依据。大量TAMs与临床病理特征、肿瘤复发和患者生存相关。研究者使用SPSS进行数据分析。研究结果显示,肿瘤浸润前沿(TIF)含有高密度TAMs的患者其整体和局部肿瘤复

肿瘤相关巨噬细胞(TAMs)对促进肿瘤发展和对癌症存活率具有一定影响。但是TAMs对肝门部胆管癌的肿瘤进展和预后的影响是鲜为人知的。

研究者分析了手术切除的肝门部胆管癌肿瘤标本(n = 47)中ATMs的分布和定位,以CD68的表达为依据。大量TAMs与临床病理特征、肿瘤复发和患者生存相关。研究者使用SPSS进行数据分析。

研究结果显示,肿瘤浸润前沿(TIF)含有高密度TAMs的患者其整体和局部肿瘤复发更高(P值均<0.05)。此外,高密度TAMs会导致总生存率的下降(一年:83.6% vs.75.1%;三年:61.3% vs.42.4%;P值均<0.05),无复发生存率的下降(一年:93.9% vs. 57.4%;三年:59.8% vs.26.2%;P值均<0.05)。多因素生存分析提示TIF中TAMs含量和肿瘤复发是独立预后因素(P值均<0.05)。

研究结果表明,TIF区中TAMs水平低的肝门部胆管癌患者与TAMs含量高的患者相比,其总体生存率和无复发生存率更高。这些结果表明,常规组织病理学检测TAMs可作为评价预后的标志物,并可能预示未来的治疗方法。

原始出处:

Atanasov G, Hau HM, Dietel C,et al.Prognostic significance of macrophage invasion in hilar cholangiocarcinoma.BMC Cancer. 2015 Oct 24;15:790. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1974664, encodeId=534919e466428, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jun 27 13:03:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56964, encodeId=726e56964dc, content=分享谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 17:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510540, encodeId=a2961510540b3, content=<a href='/topic/show?id=589b815113c' target=_blank style='color:#2F92EE;'>#肝门部胆管癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81511, encryptionId=589b815113c, topicName=肝门部胆管癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cae10200112, createdName=小刀医生, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546221, encodeId=4ee915462213e, content=<a href='/topic/show?id=a6fa100185d7' target=_blank style='color:#2F92EE;'>#预后意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100185, encryptionId=a6fa100185d7, topicName=预后意义)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628259, encodeId=cc711628259ce, content=<a href='/topic/show?id=9a4e83503e4' target=_blank style='color:#2F92EE;'>#胆管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83503, encryptionId=9a4e83503e4, topicName=胆管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21721182790, createdName=cmj15wellington, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50775, encodeId=edd550e7567, content=好学习很值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Dec 31 12:50:00 CST 2015, time=2015-12-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1974664, encodeId=534919e466428, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jun 27 13:03:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56964, encodeId=726e56964dc, content=分享谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 17:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510540, encodeId=a2961510540b3, content=<a href='/topic/show?id=589b815113c' target=_blank style='color:#2F92EE;'>#肝门部胆管癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81511, encryptionId=589b815113c, topicName=肝门部胆管癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cae10200112, createdName=小刀医生, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546221, encodeId=4ee915462213e, content=<a href='/topic/show?id=a6fa100185d7' target=_blank style='color:#2F92EE;'>#预后意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100185, encryptionId=a6fa100185d7, topicName=预后意义)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628259, encodeId=cc711628259ce, content=<a href='/topic/show?id=9a4e83503e4' target=_blank style='color:#2F92EE;'>#胆管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83503, encryptionId=9a4e83503e4, topicName=胆管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21721182790, createdName=cmj15wellington, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50775, encodeId=edd550e7567, content=好学习很值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Dec 31 12:50:00 CST 2015, time=2015-12-31, status=1, ipAttribution=)]
    2016-01-13 Lynee劲飞扬

    分享谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1974664, encodeId=534919e466428, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jun 27 13:03:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56964, encodeId=726e56964dc, content=分享谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 17:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510540, encodeId=a2961510540b3, content=<a href='/topic/show?id=589b815113c' target=_blank style='color:#2F92EE;'>#肝门部胆管癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81511, encryptionId=589b815113c, topicName=肝门部胆管癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cae10200112, createdName=小刀医生, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546221, encodeId=4ee915462213e, content=<a href='/topic/show?id=a6fa100185d7' target=_blank style='color:#2F92EE;'>#预后意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100185, encryptionId=a6fa100185d7, topicName=预后意义)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628259, encodeId=cc711628259ce, content=<a href='/topic/show?id=9a4e83503e4' target=_blank style='color:#2F92EE;'>#胆管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83503, encryptionId=9a4e83503e4, topicName=胆管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21721182790, createdName=cmj15wellington, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50775, encodeId=edd550e7567, content=好学习很值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Dec 31 12:50:00 CST 2015, time=2015-12-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1974664, encodeId=534919e466428, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jun 27 13:03:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56964, encodeId=726e56964dc, content=分享谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 17:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510540, encodeId=a2961510540b3, content=<a href='/topic/show?id=589b815113c' target=_blank style='color:#2F92EE;'>#肝门部胆管癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81511, encryptionId=589b815113c, topicName=肝门部胆管癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cae10200112, createdName=小刀医生, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546221, encodeId=4ee915462213e, content=<a href='/topic/show?id=a6fa100185d7' target=_blank style='color:#2F92EE;'>#预后意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100185, encryptionId=a6fa100185d7, topicName=预后意义)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628259, encodeId=cc711628259ce, content=<a href='/topic/show?id=9a4e83503e4' target=_blank style='color:#2F92EE;'>#胆管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83503, encryptionId=9a4e83503e4, topicName=胆管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21721182790, createdName=cmj15wellington, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50775, encodeId=edd550e7567, content=好学习很值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Dec 31 12:50:00 CST 2015, time=2015-12-31, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1974664, encodeId=534919e466428, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jun 27 13:03:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56964, encodeId=726e56964dc, content=分享谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 17:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510540, encodeId=a2961510540b3, content=<a href='/topic/show?id=589b815113c' target=_blank style='color:#2F92EE;'>#肝门部胆管癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81511, encryptionId=589b815113c, topicName=肝门部胆管癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cae10200112, createdName=小刀医生, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546221, encodeId=4ee915462213e, content=<a href='/topic/show?id=a6fa100185d7' target=_blank style='color:#2F92EE;'>#预后意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100185, encryptionId=a6fa100185d7, topicName=预后意义)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628259, encodeId=cc711628259ce, content=<a href='/topic/show?id=9a4e83503e4' target=_blank style='color:#2F92EE;'>#胆管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83503, encryptionId=9a4e83503e4, topicName=胆管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21721182790, createdName=cmj15wellington, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50775, encodeId=edd550e7567, content=好学习很值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Dec 31 12:50:00 CST 2015, time=2015-12-31, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1974664, encodeId=534919e466428, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jun 27 13:03:00 CST 2016, time=2016-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56964, encodeId=726e56964dc, content=分享谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 17:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510540, encodeId=a2961510540b3, content=<a href='/topic/show?id=589b815113c' target=_blank style='color:#2F92EE;'>#肝门部胆管癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81511, encryptionId=589b815113c, topicName=肝门部胆管癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cae10200112, createdName=小刀医生, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546221, encodeId=4ee915462213e, content=<a href='/topic/show?id=a6fa100185d7' target=_blank style='color:#2F92EE;'>#预后意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100185, encryptionId=a6fa100185d7, topicName=预后意义)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628259, encodeId=cc711628259ce, content=<a href='/topic/show?id=9a4e83503e4' target=_blank style='color:#2F92EE;'>#胆管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83503, encryptionId=9a4e83503e4, topicName=胆管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21721182790, createdName=cmj15wellington, createdTime=Fri Jan 01 13:03:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50775, encodeId=edd550e7567, content=好学习很值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Dec 31 12:50:00 CST 2015, time=2015-12-31, status=1, ipAttribution=)]
    2015-12-31 忠诚向上

    好学习很值得

    0

相关资讯

Gastroenterology:新辅助化放疗序贯肝移植对肝门部胆管癌有效

    《胃肠病学》杂志(Gastroenterology)7月刊发的一项多中心回顾性研究显示,新辅助化放疗序贯肝移植治疗不可切除性肝门部胆管癌有效且合理(Gastroenterology 2012 July [doi: 10.1053/j.gastro.2012.04.008])。      2006年,基于化放疗/移植方案的

肝门部胆管癌诊断和治疗指南 (2013版)

肝门部胆管癌是指累及肝总管、左右肝管及其汇合部的胆管黏膜上皮癌,亦称高位胆管癌、近端胆管癌或Klatskin肿瘤。肝门部胆管癌的发病率呈逐年增高的趋势,尸检资料显示胆管癌的发病率约为0.01%~0.20%,肝门部胆管癌占其中的40%~60%。肝门部胆管癌被认为是肝胆外科一领域最具挑战性的难题之一,由于缺乏符合我国国情的临床实践指南,在肝门部胆管癌病情评估、治疗决策、手术方式及非手术治疗等方面普遍存

Surgery:肝门部胆管癌患者不应常规行门静脉切除

对肝门部胆管癌(HCA)行肝切除术 (LR)依旧存在很多挑战,因为血管和单管的侵犯是无法预料的。手术的目标之一是达到切缘无肿瘤浸润,而常规门静脉切除术(PVR) 对患者的利弊一直饱受争议。研究者纳入了60例行了LR的HCA病例。其中有21(35.0%)名病人进行了LR+PVR,余下39(65.0%)名病人只行了LR。研究者通过单因素和多因素分析对数据进行处理。研究结果显示,切除术主要针对的是Bis